AstraZeneca shares fall on report of potential China probe fallout
AstraZeneca shares recorded their biggest one-day drop since March 2020 on Tuesday following a report that dozens of senior executives at its China unit could be implicated in the largest insurance fraud case in the country's pharma sector in years.
AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...
(Yicai) Nov. 6 -- Major multinational automakers, including Volkswagen Group, Ford Motor, and Stellantis, reported disappointing sales in China in the quarter ended September as the country’s rapidly ...
AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...
Chinese authorities detained AstraZeneca employees amid a probe into data privacy breaches and unlicensed drug sales, stock ...
This month’s fast rebound was partly the result of very low sales in September, the sales director at one real estate project ...
Shares plunged 8.4pc, the most in four years, after the report by Chinese state-owned news organisation Yicai claimed ...
The decision comes after media reports said it had indefinitely suspended plans to build two battery plants in Germany. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback